ProFunds Pharmaceuticals UltraSector Fund Investor Class (PHPIX)

Fund Assets	8.58M
Expense Ratio	1.726%
Min. Investment	$15,000
Turnover	373.00%
Dividend (ttm)	0.31
Dividend Yield	0.74%
Dividend Growth	17.70%
Payout Frequency	Annual
Ex-Dividend Date	Dec 30, 2025

Previous Close	40.68
YTD Return	19.62%
1-Year Return	47.29%
5-Year Return	60.14%
52-Week Low	28.00
52-Week High	50.67
Beta (5Y)	1.31
Holdings	78
Inception Date	Jun 28, 2000

About PHPIX

Pharmaceuticals UltraSector ProFund Investor Class is a leveraged mutual fund designed to provide daily investment results that correspond to 1.5 times the daily performance of the S&P Pharmaceuticals Select Industry Index. The fund tracks the pharmaceutical segment of the U.S. equity market, offering investors amplified exposure to the pharmaceutical industry through a diversified portfolio of pharmaceutical companies. The fund's index comprises 51 pharmaceutical companies and represents the pharmaceuticals sub-industry classification within the broader U.S. market. As a leveraged UltraSector fund, it is structured for investors seeking enhanced daily returns from the pharmaceutical sector, which includes major drug manufacturers and developers focused on therapeutic treatments and medications. The fund operates with an expense structure and is available in both Investor Class and Service Class share formats, providing different investment minimums and fee arrangements to accommodate various investor needs.

• Fund Family: ProFunds
• Category: Trading--Leveraged Equity
• Performance Rating: Below Average
• Risk Rating: High
• Stock Exchange: Nasdaq
• Ticker Symbol: PHPIX
• Share Class: Investor Class
• Index: S&P 500 TR

Performance

PHPIX had a total return of 47.29% in the past year, including dividends. Since the fund's inception, the average annual return has been 4.16%.

Other Share Classes

These are alternative share classes of the same fund, from the same provider.

Symbol	Share Class	Expense Ratio
PHPSX	Service Class	2.78%

Top 10 Holdings

208.00% of assets

Name	Symbol	Weight
Asset Offset	n/a	90.81%
Phpix_spsiph_goldman	n/a	52.54%
Phpix_spsiph_ubs	n/a	31.22%
Societe' Generale 3.53 , 8/03/2026	n/a	8.20%
Cf Secured 3.53 , 8/03/2026	n/a	6.31%
Natwest Markets Plc 3.51 , 8/03/2026	n/a	5.05%
Hsbc Securities (Usa), Inc. 3.52 , 8/03/2026	n/a	5.05%
Umb Financial Corp. 3.39 , 8/03/2026	n/a	3.95%
Crinetics Pharmaceuticals, Inc.	CRNX	2.60%
MBX Biosciences, Inc.	MBX	2.28%

Dividend History

Ex-Dividend	Amount	Pay Date
Dec 30, 2025	$0.30794	Dec 31, 2025
Dec 31, 2024	$0.26164	Jan 2, 2025
Dec 28, 2023	$0.11861	Dec 29, 2023
Dec 21, 2020	$0.10458	Dec 22, 2020
Dec 27, 2018	$0.79672	Dec 27, 2018
Dec 20, 2017	$1.09567	Dec 20, 2017

Data Sources: Tiingo, Twelve Data, and more

Historical data is provided by Tiingo. Delayed stock pricing data is provided by Twelve Data. Several fund data points are also provided by Finnhub.

Last checked:

Oct 31, 2026

Data Sources Report a data error